title: Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
authors.affiliation: TIMI Study Group, Boston, MA 02115, USA. eantman@rics.bwh.harvard.edu
authors.forename: Elliott M
authors.initials: EM
authors.lastname: Antman
authors.forename: David A
authors.initials: DA
authors.lastname: Morrow
authors.forename: Carolyn H
authors.initials: CH
authors.lastname: McCabe
authors.forename: Frank
authors.initials: F
authors.lastname: Jiang
authors.forename: Harvey D
authors.initials: HD
authors.lastname: White
authors.forename: Keith A A
authors.initials: KA
authors.lastname: Fox
authors.forename: Divakar
authors.initials: D
authors.lastname: Sharma
authors.forename: Paul
authors.initials: P
authors.lastname: Chew
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
mesh_terms: D004311:Double-Blind Method; D004562:Electrocardiography; D017984:Enoxaparin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012107:Research Design; D015912:Thrombolytic Therapy
chemical_list: D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006493:Heparin